RC
LLY icon

Rovin Capital’s Eli Lilly LLY Stock Holding History

Rovin Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$743K Buy
691
+150
+28% +$143K 0.2% 90
2025
Q3 		$413K Buy
541
+144
+36% +$107K 0.11% 136
2025
Q2 		$309K Buy
397
+42
+12% +$32.6K 0.09% 159
2025
Q1 		$293K Sell
355
-39
-10% -$32.5K 0.09% 152
2024
Q4 		$304K Sell
394
-11
-3% -$9.11K 0.11% 131
2024
Q3 		$359K Buy
405
+153
+61% +$138K 0.13% 129
2024
Q2 		$228K Sell
252
-6
-2% -$4.8K 0.1% 151
2024
Q1 		$201K Buy
+258
New +$184K 0.08% 153

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Rovin Capital's LLY Position: Q4 2025 in Review

Rovin Capital increased its Eli Lilly (LLY) stake by 28% in Q4 2025, buying an estimated $143K and bringing the position to 691 shares worth $743K. The position accounts for 0.2% of the portfolio, ranked #90.

Rovin Capital first reported a position in LLY in Q1 2024 and has held it in 8 quarters since. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Rovin Capital held 691 shares of Eli Lilly worth $743K as of Q4 2025.
  • Rovin Capital bought 150 Eli Lilly shares in Q4 2025, an estimated $143K.
  • Eli Lilly made up 0.2% of Rovin Capital's portfolio in Q4 2025, its #90 holding.
  • Rovin Capital first reported a position in Eli Lilly in Q1 2024 and has held it in 8 quarters since.
  • 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Rovin Capital's 13F filing for Q4 2025, filed 9 Feb 2026.